2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Implications for emergency department practice

被引:32
作者
Pollack, CV
Roe, MT
Peterson, ED
机构
[1] Hosp Univ Penn, Dept Emergency Med, Hlth Syst, Philadelphia, PA 19107 USA
[2] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
关键词
D O I
10.1067/mem.2003.88
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The publication of comprehensive evidence-based guidelines for the management of non-ST-segment elevation acute coronary syndrome by the American College of Cardiology and the American Heart Association in September 2000 marked a sentinel event in the evolution of managing this challenging patient population. Many of the recommendations included in the guidelines have relevance to the emergency department care of patients with non-ST-segment elevation acute coronary syndrome and were summarized in Annals of Emergency Medicine in September 2001. New clinical data in this area continue to accumulate at a remarkably rapid rate, prompting the American College of Cardiology and the American Heart Association to publish an update of the 2000 guidelines in October 2002. Several of the modified and new recommendations again potentially affect ED management. These are presented and discussed here.
引用
收藏
页码:355 / 369
页数:15
相关论文
共 44 条
[11]  
Braunwald E, 1994, AHCPR PUBLICATION, P1
[12]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[13]   A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease [J].
Cohen, M ;
Demers, C ;
Gurfinkel, EP ;
Turpie, AGG ;
Fromell, GJ ;
Goodman, S ;
Langer, A ;
Califf, RM ;
Fox, KAA ;
Premmereur, J ;
Bigonzi, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) :447-452
[14]  
Cohen M, 2000, CIRCULATION, V102, P826
[15]  
Collet JP, 2001, CIRCULATION, V103, P658
[16]   Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide [J].
Goodman, SG ;
Fitchett, D ;
Armstrong, PW ;
Tan, M ;
Langer, A .
CIRCULATION, 2003, 107 (02) :238-244
[17]   Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes [J].
Greenbaum, AB ;
Harrington, RA ;
Hudson, MP ;
MacAulay, CM ;
Wilcox, RG ;
Simoons, ML ;
Berdan, LG ;
Guerci, A ;
Cokkinos, DV ;
Kitt, MM ;
Lincoff, AM ;
Topol, EJ ;
Califf, RM ;
Ohman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :492-498
[18]  
JESSE RL, 2002, WORLD C CARD MAY
[19]  
Kereiakes D J, 2001, J Invasive Cardiol, V13, P272
[20]   Dalteparin in combination with abciximab during percutaneous coronary intervention [J].
Kereiakes, DJ ;
Kleiman, NS ;
Fry, E ;
Mwawasi, G ;
Lengerich, R ;
Maresh, K ;
Burkert, ML ;
Aquilina, JW ;
DeLoof, M ;
Broderick, TM ;
Shimshak, TM .
AMERICAN HEART JOURNAL, 2001, 141 (03) :348-352